KRAS G12C inhibitor 30
KRAS G12C inhibitor 30 is a KRAS G12C inhibitor extracted from patent WO2021252339A1, compound 2. KRAS G12C inhibitor 30 can be used for the research of cancer[1].
Product Specifications
CAS Number
2752352-90-0
UNSPSC
12352005
Target
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kras-g12c-inhibitor-30.html
Solubility
10 mM in DMSO
Smiles
O=C(NC1=CC=CC(N2C3=NC4=C(N3CCC2)C(N(CC5=C(Cl)C=CC=C5F)C(N4C)=O)=O)=C1)C=C
Molecular Formula
C25H22ClFN6O3
Molecular Weight
508.93
References & Citations
[1]Fan J, et, al. Substituted purine-2,6-dione compounds as kras inhibitors. WO2021252339A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940204-100 1x 100 µL
Complement C4d (C4D204), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470178-500 1x 500 µL
CD50 (ICAM-3) (186-2G9), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400821-500 1x 500 µL
Caldesmon, HMW (h-Caldesmon) (CALD1/820 + h-CALD), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940681-500 1x 500 µL
Human Kappa Light Chain (HP6053), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details